(Child & Family Research Institute) Phase 2 study results show high-dose imatinib plus chemo more than doubled survival for high risk type of childhood leukemia.
New treatment more than doubles survival for high risk childhood...Courtesy EurekAlert! - Cancer Mon, 10/05/2009 - 22:00
(Child & Family Research Institute) Phase 2 study results show high-dose imatinib plus chemo more than doubled survival for high risk type of childhood leukemia. More related itemsKids, Cancer and Clinical Trials: Parents Are Confused
New drug for children with high-risk leukemia
Strokes can strike kids
Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
|
Popular by tags WeekMonth |
Post new comment